Fig. 4 | Scientific Reports

Fig. 4

From: Screening and evaluation of specific blood MiRNAs as potential biomarkers in diagnostics of gastric Cancer

Fig. 4

The expression of key miRNAs in human blood specimens by RT-qPCR detection and the correlation with the stages. (A) The expression of hsa-miR-124-3p increased in the blood samples of GC patients (P < 0.01 vs. normal). (B) The blood expression of hsa-miR-125a-3p decreased in the blood samples of GC patients (P < 0.01 vs. normal). (C) The expression of hsa-miR-29b-3p increased in the blood samples of GC patients (P < 0.05 vs. normal). (D) The expression of hsa-miR-4276 decreased in the blood samples of GC patients (P < 0.01 vs. normal). (E) The expression of hsa-miR-575 decreased in the blood samples of GC patients (P < 0.01 vs. normal). (F) The expression levels of key miRNAs in different stages of pTNM (P < 0.05 vs. Stage I).

Back to article page